Tretinoin
- Product NDC
- 42291-870
- 11-digit product format
- 422910870
- Labeler code
- 42291
- Product ID
- 42291-870_d8b55fe6-3e3c-1bac-e053-2995a90a9bfe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tretinoin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA208279
- Marketing category
- ANDA
- Marketing start
- 2022-02-23
- Marketing end
- 0000-00-00
- Substance
- TRETINOIN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-870 | TRETINOIN CAPSULE [AVKARE] | 2 | Legacy NDC | 20240111_d8b55a7c-4d05-08b0-e053-2995a90ae42c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-870-01 | 42291087001 | 100 CAPSULE in 1 BOTTLE (42291-870-01) | 100 capsule | 2022-02-23 | 0000-00-00 | No | No | Current |